Personal Information
Organization / Workplace
Greater New York City Area United States
Occupation
Principal Consultant, 20/20 Market Insights, LLC
Industry
Medical / Health Care / Pharmaceuticals
About
Will Roettger is an established career professional in the pharmaceutical and biotech industry with extensive experience in specialty therapeutic areas of oncology, hematology, immunology, and rare disease for pipeline and launch products. He has been successful in establishing marketing intelligence as a core capability in support of clinical and commercial new product development - solving the many commercial challenges that specialty products face from a patient, provider, and investor perspective. His success is attributed to the integration of his drug development knowledge, market research, and competitive intelligence in order to provide compelling insights and strategic recommenda...
Tags
oncology
market research
leukemia
biotechnology
lymphoma
nsclc
pharmaceutical
marketing
cll
oncology drug development
hematology
dlbcl
hematology-oncology
genentech
lambrolizumab
nivolumab
roche
pidilizumab
bristol myers squibb
mpdl3280a
melanoma
merck
competitive intelligence
crc
colorectal cancer
drug development
cancer treatment
multiple myeloma
aml
all
targeted agents
oncology reports
idealilisib
ibrutinib
duvelisib
chronic lymphocytic leukemia
drug development strategy
clinical drug development
commercial drug development
oncology drug treatments
market assessments
drug profiling
drug launch prediction
car-t cell
market assessment
acute lymphocytic leukemia
reports
nhl
curetech
bms936559
immune checkpoints
programmed death-1
renal cell carcinoma
ctla-4
pd-1. pd-l1
rare disease
cold agglutinin disease
cad
rituximab
rituxan
plasmapheresis
anemia
aiha
autoimmune hemolytic anemia
immunotherapy
bms936558
mk-3475
pd-1
pd-l1
ct-011
eli lilly
duration-4
novo nordisk
byetta
metformin
pioglit
bydureon
amylin
actos
exenatide. januvia
alkermes
afatanib
bif1120
tomtovok
nintedanib
clinical trial
stivarga
sorafenib
regorafenib
nexavar
bay 73-4506
oncology products
bayer oncology
non small cell lung cancer
market research plan
product launch
avastin
erbitux
schizophrenia
anti-psychotic
pharmaceutical drugs
boehringer ingelheim
tovok
vargatef
neurogenic orthostatic hypotension
noh
chelsea therapeutics
northera
drug launch plan
pharmaceutical drug
See more
- Presentations
- Documents
- Infographics
Chelsea Therapeutics - Northera NOH 2011 Market Research Plan
Will Roettger
•
11 years ago
Newly Diagnosed Myeloma
spa718
•
9 years ago
Small cell lung cancer
Osama Elzaafarany, MD.
•
9 years ago
Immuno-Oncology: A Colloquium on the State of the Science for Oncology Clinicians
Institute For Medical Education and Research (IMER)
•
11 years ago
Immuno-Oncology: An Evolving Approach to Cancer Care
Institute For Medical Education and Research (IMER)
•
11 years ago
2012 genitourinary con
Adonis Guancia
•
11 years ago